MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
MAXON™ sutures retain approximately 75% of initial tensile strength at two weeks, 65% of at three weeks and 50% at four weeks post-implant
Absorption of MAXON™ sutures is minimal until about 60 days after implant and is essentially complete within six months
This product is required to be reported under California Proposition 65
Manufacturer # 8886623241
Brand Maxon™
Manufacturer Covidien
Country of Origin Unknown
Application Absorbable Suture with Needle
Coating Uncoated
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
Needle 1 Code V-20
Needle Length 26 mm
Needle Length Range 20.1 to 40 mm
Needle Shape 1/2 Circle
Needle Type Taper Point Needle
Number of Needles 1-Needle
On_Allocation N
Supplier_ID 487778
Suture Color Clear
Suture Length 30 Inch
Suture Length Range 20.1 to 40 in
Suture Material Polyglyconate
Suture Material Range Undyed Synthetic
Suture Size Size 3 - 0
Suture Type Monofilament
UNSPSC Code 42312201
